Author Marry Hall Published April 22, 2021 Word count 513 Facial skin more than often doesn’t get the attention and care that it really deserves. While everyone deals with a different skin type that needs an equally different care regime, people usually fail to understand this fact and tend to go for generalized treatment packages… Read More: Do You Know Which Facial Treatment Is the Best for… »
Prostate cancer is often a multifocal disease, meaning that several tumors can be present in different parts of gland at the same time. Not all of these tumors are equally problematic, however. And it’s increasingly thought that the tumor with the most aggressive features — called the index lesion — dictates how a man’s cancer… Read More: An emerging treatment option for men with recurring prostate cancer… »
Article content continued “It’s entirely possible that by the time you’re giving it, you’re giving it too late.” Medical technicians work at a drive-through COVID-19 testing facility at the Regeneron Pharmaceuticals company’s Westchester campus in Tarrytown, New York, September 17, 2020. Photo by Brendan McDermid/Reuters/File That Trump got something wholly experimental has raised eyebrows, but… Read More: All about monoclonal antibody drugs — the experimental treatment that… »
PRINCETON, N.J.–(BUSINESS WIRE) October 2, 2020 — Bristol Myers Squibb (NYSE: BMY) today announced that Opdivo (nivolumab) 360 mg every three weeks plus Yervoy (ipilimumab) 1 mg/kg every six weeks (injections for intravenous use) was approved by the U.S. Food and Drug Administration (FDA) for the first-line treatment of adult patients with unresectable malignant pleural… Read More: FDA Approves Opdivo (nivolumab) + Yervoy (ipilimumab) as the First… »